CRISPR/Cas9-mediated CD39 disruption can be combined with TCR editing in T cells to improve the adoptive T cell therapy of colorectal cancerAlessia Potenza,Chiara Balestrieri,Luca Albarello,Federica Pedica,Lorena Stasi,Francesco Manfredi, Martina Spiga,Elena Tassi,Beatrice Claudia Cianciotti,Danilo Abbati,Ugo Elmore,Andrea Biondi,Luca Aldrighetti,Claudia De Lalla,Giulia Di Lullo,Paolo Dellabona,Eliana Ruggiero,Riccardo Rosati,Chiara BoniniHUMAN GENE THERAPY(2022)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要